2. TaskForce Finance Meeting

Agenda:

•           Welcome by KPMG

•           Workshop: “Going Concern – A Unique Challenge for Biotech Companies”

The workshop was led by Stephanie Sauer (KPMG Law Senior Manager) and Michael Klewan (KPMG Audit Senior Manager).

Content:

•           The business model of biotech companies in light of corporate and insolvency law

•           Critical issues from practice

•           Duties of the legal representatives of biotech companies

•           Duties of the auditor in the context of the audit

•           Measures to avoid or address critical issues

•           Disclosure obligations in the annual financial statements

•           Dos and Don’ts

•           Modifications to the auditor’s opinion related to Going Concern